# Liminatus Pharma, Inc.: Form 8-K, filed Feb 9, 2026

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K
- Filed: 2026-02-09
- Accepted by EDGAR: Feb 9, 2026, 15:01 ET
- Period: 2026-02-06
- Accession: 0001104659-26-012016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/tm265593d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/tm265593d1_8k.htm

Filed Feb 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-012016. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.